These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29424469)

  • 1. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Obes Metab; 2018 Jun; 20(6):1499-1502. PubMed ID: 29424469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
    Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
    Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
    Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
    Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control.
    Tsujimoto T; Kajio H
    Hypertension; 2018 Aug; 72(2):323-330. PubMed ID: 29967045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
    Adler AI; Stratton IM; Neil HA; Yudkin JS; Matthews DR; Cull CA; Wright AD; Turner RC; Holman RR
    BMJ; 2000 Aug; 321(7258):412-9. PubMed ID: 10938049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis.
    Grenet G; Le HH; Bejan-Angoulvant T; Erpeldinger S; Boussageon R; Kassaï B; Moulin P; Gueyffier F; Cucherat M
    Diabetes Metab; 2019 Dec; 45(6):550-556. PubMed ID: 31150802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.
    Dungan K; Craven TE; Soe K; Wright JT; Basile J; Haley WE; Kressin NR; Rani U; Tamariz L; Whittle J; Wiggers A; Osei K
    Diabetes Obes Metab; 2018 Mar; 20(3):629-637. PubMed ID: 29024310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial.
    White WB; Jalil F; Cushman WC; Bakris GL; Bergenstal R; Heller SR; Liu Y; Mehta C; Zannad F; Cannon CP
    J Am Heart Assoc; 2018 Oct; 7(20):e009114. PubMed ID: 30371278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Cushman WC; Grimm RH; Cutler JA; Evans GW; Capes S; Corson MA; Sadler LS; Alderman MH; Peterson K; Bertoni A; Basile JN;
    Am J Cardiol; 2007 Jun; 99(12A):44i-55i. PubMed ID: 17599425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment: A Prospective Cohort Study.
    Laugesen E; Knudsen ST; Hansen KW; Rossen NB; Jensen LO; Hansen MG; Munkholm H; Thomsen KK; Søndergaard H; Bøttcher M; Raungaard B; Madsen M; Hulman A; Witte D; Bøtker HE; Poulsen PL
    Hypertension; 2016 Sep; 68(3):768-74. PubMed ID: 27402917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).
    Redon J; Mancia G; Sleight P; Schumacher H; Gao P; Pogue J; Fagard R; Verdecchia P; Weber M; Böhm M; Williams B; Yusoff K; Teo K; Yusuf S;
    J Am Coll Cardiol; 2012 Jan; 59(1):74-83. PubMed ID: 22192672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after tight control of blood pressure in type 2 diabetes.
    Holman RR; Paul SK; Bethel MA; Neil HA; Matthews DR
    N Engl J Med; 2008 Oct; 359(15):1565-76. PubMed ID: 18784091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
    Bangalore S; Kumar S; Lobach I; Messerli FH
    Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More Versus Less Intensive Blood Pressure-Lowering Strategy: Cumulative Evidence and Trial Sequential Analysis.
    Verdecchia P; Angeli F; Gentile G; Reboldi G
    Hypertension; 2016 Sep; 68(3):642-53. PubMed ID: 27456518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.
    Vazquez-Benitez G; Desai JR; Xu S; Goodrich GK; Schroeder EB; Nichols GA; Segal J; Butler MG; Karter AJ; Steiner JF; Newton KM; Morales LS; Pathak RD; Thomas A; Reynolds K; Kirchner HL; Waitzfelder B; Elston Lafata J; Adibhatla R; Xu Z; O'Connor PJ
    Diabetes Care; 2015 May; 38(5):905-12. PubMed ID: 25710922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive treatment in Asian populations: a meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA).
    Yano Y; Briasoulis A; Bakris GL; Hoshide S; Wang JG; Shimada K; Kario K
    J Am Soc Hypertens; 2014 Feb; 8(2):103-16. PubMed ID: 24157055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
    Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
    J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.